Semaphorins and tumor angiogenesis

Tran TS et al (2007) Semaphorin regulation of cellular morphology. Annu Rev Cell Dev Biol 23:263–292. doi:10.1146/annurev.cellbio.22.010605.093554 Bussolino F et al (2006) Semaphoring vascular morphogenesis. Endothelium 13:81–91. doi:10.1080/10623320600698003 Gitler AD et al (2004) PlexinD1 and semaphorin signaling are required in endothelial cells for cardiovascular development. Dev Cell 7:107–116. doi:10.1016/j.devcel.2004.06.002 Zhang Y et al (2009) Tie2Cre-mediated inactivation of plexinD1 results in congenital heart, vascular and skeletal defects. Dev Biol 325:82–93. doi:10.1016/j.ydbio.2008.09.031 Neufeld G, Kessler O (2008) The semaphorins: versatile regulators of tumour progression and tumour angiogenesis. Nat Rev Cancer 8:632–645. doi:10.1038/nrc2404 Zhou Y et al (2008) Semaphorin signaling: progress made and promises ahead. Trends Biochem Sci 33:161–170. doi:10.1016/j.tibs.2008.01.006 Luo BH, Springer TA (2006) Integrin structures and conformational signaling. Curr Opin Cell Biol 18:579–586. doi:10.1016/j.ceb.2006.08.005 Valdembri D et al. (2009) Neuropilin-1/GIPC1 signaling regulates α5β1 integrin traffic and function in endothelial cells. PLoS Biol 7(1):e1000025. doi:10.1371/journal.pbio.1000025 Barberis D et al (2004) Plexin signaling hampers integrin-based adhesion, leading to Rho-kinase independent cell rounding, and inhibiting lamellipodia extension and cell motility. FASEB J 18:592–594 Butler B et al (2006) Purified integrin adhesion complexes exhibit actin-polymerization activity. Curr Biol 16:242–251. doi:10.1016/j.cub.2005.12.033 Takahashi T, Strittmatter SM (2001) Plexina1 autoinhibition by the plexin sema domain. Neuron 29:429–439. doi:10.1016/S0896-6273(01)00216-1 Oinuma I et al (2004) The Semaphorin 4D receptor Plexin-B1 is a GTPase activating protein for R-Ras. Science 305:862–865. doi:10.1126/science.1097545 Negishi M et al (2005) R-ras as a key player for signaling pathway of plexins. Mol Neurobiol 32:217–222. doi:10.1385/MN:32:3:217 Oinuma I et al (2004) Molecular dissection of the semaphorin 4D receptor plexin-B1-stimulated R-Ras GTPase-activating protein activity and neurite remodeling in hippocampal neurons. J Neurosci 24:11473–11480. doi:10.1523/JNEUROSCI.3257-04.2004 Kinbara K et al (2003) Ras GTPases: integrins’ friends or foes? Nat Rev Mol Cell Biol 4:767–776 Toyofuku T et al (2005) FARP2 triggers signals for Sema3A-mediated axonal repulsion. Nat Neurosci 8:1712–1719. doi:10.1038/nn1596 Critchley DR, Gingras AR (2008) Talin at a glance. J Cell Sci 121:1345–1347. doi:10.1242/jcs.018085 Conrotto P et al (2005) Sema4D induces angiogenesis through Met recruitment by Plexin B1. Blood 105:4321–4329. doi:10.1182/blood-2004-07-2885 Basile JR et al (2004) Class IV semaphorins promote angiogenesis by stimulating Rho-initiated pathways through plexin-B. Cancer Res 64:5212–5224. doi:10.1158/0008-5472.CAN-04-0126 Basile JR et al (2005) Semaphorin 4D/plexin-B1 induces endothelial cell migration through the activation of PYK2, Src, and the phosphatidylinositol 3-kinase-Akt pathway. Mol Cell Biol 25:6889–6898. doi:10.1128/MCB.25.16.6889-6898.2005 Swiercz JM et al (2004) Plexin-B1/RhoGEF-mediated RhoA activation involves the receptor tyrosine kinase ErbB-2. J Cell Biol 165:869–880. doi:10.1083/jcb.200312094 Swiercz JM et al (2008) ERBB-2 and met reciprocally regulate cellular signaling via plexin-B1. J Biol Chem 283:1893–1901. doi:10.1074/jbc.M706822200 Toyofuku T et al (2007) Semaphorin-4A, an activator for T-cell-mediated immunity, suppresses angiogenesis via Plexin-D1. EMBO J 26:1373–1384. doi:10.1038/sj.emboj.7601589 Soker S et al (1998) Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92:735–745. doi:10.1016/S0092-8674(00)81402-6 Kawasaki T et al (1999) A requirement for neuropilin-1 in embryonic vessel formation. Development 126:4895–4902 Favier B et al (2006) Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration. Blood 108:1243–1250. doi:10.1182/blood-2005-11-4447 Karpanen T et al (2006) Functional interaction of VEGF-C and VEGF-D with neuropilin receptors. FASEB J 20:1462–1472. doi:10.1096/fj.05-5646com Matsushita A et al (2007) Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1. Cancer Res 67:10309–10316. doi:10.1158/0008-5472.CAN-07-3256 Appleton BA et al (2007) Structural studies of neuropilin/antibody complexes provide insights into semaphorin and VEGF binding. EMBO J 26:4902–4912. doi:10.1038/sj.emboj.7601906 Miao HQ et al (1999) Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165. J Cell Biol 146:233–242 West DC et al (2005) Interactions of multiple heparin binding growth factors with neuropilin-1 and potentiation of the activity of fibroblast growth factor-2. J Biol Chem 280:13457–13464. doi:10.1074/jbc.M410924200 Migdal M et al (1998) Neuropilin-1 is a placenta growth factor-2 receptor. J Biol Chem 273:22272–22278. doi:10.1074/jbc.273.35.22272 Glinka Y, Prud’homme GJ (2008) Neuropilin-1 is a receptor for transforming growth factor beta-1, activates its latent form, and promotes regulatory T cell activity. J Leukoc Biol 84:302–310. doi:10.1189/jlb.0208090 Hu B et al (2007) Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway. Oncogene 26:5577–5586. doi:10.1038/sj.onc.1210348 Banerjee S et al (2006) Breast cancer cells secreted platelet-derived growth factor-induced motility of vascular smooth muscle cells is mediated through neuropilin-1. Mol Carcinog 45:871–880. doi:10.1002/mc.20248 Hsieh SH et al (2008) Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells. Oncogene 27:3746–3753. doi:10.1038/sj.onc.1211029 Herzog Y et al (2005) Segregation of arterial and venous markers in subpopulations of blood islands before vessel formation. Dev Dyn 232:1047–1055. doi:10.1002/dvdy.20257 Herzog Y et al (2001) Differential expression of neuropilin-1 and neuropilin-2 in arteries and veins. Mech Dev 109:115–119. doi:10.1016/S0925-4773(01)00518-4 Toyofuku T et al (2004) Dual roles of Sema6D in cardiac morphogenesis through region-specific association of its receptor, Plexin-A1, with off-track and vascular endothelial growth factor receptor type 2. Genes Dev 18:435–447. doi:10.1101/gad.1167304 Bussolino F et al (1992) Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 119:629–641. doi:10.1083/jcb.119.3.629 Gu C et al (2005) Semaphorin 3E and plexin-D1 control vascular pattern independently of neuropilins. Science 307:265–268. doi:10.1126/science.1105416 Behar O et al (1996) Semaphorin III is needed for normal patterning and growth of nerves, bones and heart. Nature 383:525–528. doi:10.1038/383525a0 Kanda T et al (2007) PlexinD1 deficiency induces defects in axial skeletal morphogenesis. J Cell Biochem 101:1329–1337. doi:10.1002/jcb.21306 Towler DA (2007) Vascular biology and bone formation: hints from HIF. J Clin Invest 117:1477–1480. doi:10.1172/JCI32518 Wang Y et al (2007) The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. J Clin Invest 117:1616–1626. doi:10.1172/JCI31581 Gomez C et al (2005) Expression of Semaphorin-3A and its receptors in endochondral ossification: potential role in skeletal development and innervation. Dev Dyn 234:393–403. doi:10.1002/dvdy.20512 Futamura M et al (2007) Possible role of semaphorin 3F, a candidate tumor suppressor gene at 3p21.3, in p53-regulated tumor angiogenesis suppression. Cancer Res 67:1451–1460. doi:10.1158/0008-5472.CAN-06-2485 Sekido Y et al (1996) Human semaphorins A(V) and IV reside in the 3p21.3 small cell lung cancer deletion region and demonstrate distinct expression patterns. Proc Natl Acad Sci USA 93:4120–4125. doi:10.1073/pnas.93.9.4120 Potiron VA et al (2009) Semaphorins and their receptors in lung cancer. Cancer Lett 273:1–14. doi:10.1016/j.canlet.2008.05.032 Bielenberg DR et al (2004) Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype. J Clin Invest 114:1260–1271 Kessler O et al (2004) Semaphorin-3F is an inhibitor of tumor angiogenesis. Cancer Res 64:1008–1015. doi:10.1158/0008-5472.CAN-03-3090 Serini G et al (2003) Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function. Nature 424:391–397. doi:10.1038/nature01784 Acevedo LM et al (2008) Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor. Blood 111:2674–2680. doi:10.1182/blood-2007-08-110205 Serini G et al (2008) Integrins team up with tyrosine kinase receptors and plexins to control angiogenesis. Curr Opin Hematol 15:235–242. doi:10.1097/MOH.0b013e3282fa745b Maione F et al. (2009) Semaphorin 3A is an endogenous angiogenic inhibitor that blocks tumor growth and normalizes the vasculature in a mouse model of multistage tumorigenesis. J Clin Invest (submitted) Serini G et al (2006) Integrins and angiogenesis: a sticky business. Exp Cell Res 312:651–658. doi:10.1016/j.yexcr.2005.10.020 Casanovas O et al (2005) Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. Cancer Cell 8:299–309. doi:10.1016/j.ccr.2005.09.005 Jain RK (2008) Lessons from multidisciplinary translational trials on anti-angiogenic therapy of cancer. Nat Rev Cancer 8:309–316. doi:10.1038/nrc2346 Jain RK (2005) Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307:58–62. doi:10.1126/science.1104819 Jain RK et al (2007) Angiogenesis in brain tumours. Nat Rev Neurosci 8:610–622. doi:10.1038/nrn2175 Lee S et al (2007) Autocrine VEGF signaling is required for vascular homeostasis. Cell 130:691–703. doi:10.1016/j.cell.2007.06.054 Serini G et al (2003) Modeling the early stages of vascular network assembly. EMBO J 22:1771–1779. doi:10.1093/emboj/cdg176 Tang N et al (2004) Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis. Cancer Cell 6:485–495. doi:10.1016/j.ccr.2004.09.026 Damon DH (2006) Vascular endothelial-derived semaphorin 3 inhibits sympathetic axon growth. Am J Physiol Heart Circ Physiol 290:H1220–H1225. doi:10.1152/ajpheart.01232.2004 Ito T et al (2000) Repulsive axon guidance molecule Sema3A inhibits branching morphogenesis of fetal mouse lung. Mech Dev 97:35–45. doi:10.1016/S0925-4773(00)00401-9 Vacca A et al (2006) Loss of inhibitory semaphorin 3A (SEMA3A) autocrine loops in bone marrow endothelial cells of patients with multiple myeloma. Blood 108:1661–1667. doi:10.1182/blood-2006-04-014563 Basile JR et al (2007) Plexin-B1 utilizes RhoA and Rho kinase to promote the integrin-dependent activation of Akt and ERK and endothelial cell motility. J Biol Chem 282:34888–34895. doi:10.1074/jbc.M705467200 Basile JR et al (2006) Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis. Proc Natl Acad Sci USA 103:9017–9022. doi:10.1073/pnas.0508825103 Sierra JR et al (2008) Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages. J Exp Med 205:1673–1685. doi:10.1084/jem.20072602 Giordano S et al (2002) The semaphorin 4D receptor controls invasive growth by coupling with Met. Nat Cell Biol 4:720–724. doi:10.1038/ncb843 Folkman J (2006) Angiogenesis. Annu Rev Med 57:1–8. doi:10.1146/annurev.med.57.121304.131306